Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)

    NIH funds U.S. small businesses partnering with nonprofit research institutions to commercialize scientific innovations, supporting feasibility studies through later-stage research and development.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: National Institutes of Health

    Due Dates: September 5, 2026 (Applications) | January 5, 2027 (Applications) | April 5, 2027 (Applications)

    Funding Amounts: Component-specific budgets below; normally up to 1 year for Phase I and 2 years for Phase II; no match required

    Summary: Supports U.S. small businesses partnering with nonprofit research institutions to develop and commercialize health-related scientific innovations.

    Key Information: The small business must perform at least 40% of research effort, and its single research partner at least 30%.


    Description

    NIH’s Small Business Technology Transfer program funds research and development that moves scientific innovations toward commercial products. This parent opportunity, PA-27-102, supports feasibility studies through later-stage development aligned with participating NIH Institutes’ and Centers’ missions. Projects require a formal collaboration between a U.S. small business and a nonprofit research institution or qualifying federally funded research and development center. The award is always made to the small business.

    Applications may seek Phase I, Phase II, Direct to Phase II, or Fast-Track support. Clinical trials are optional, subject to component-specific exclusions. After Phase II, NIH expects recipients to commercialize their products or technologies using non-SBIR/STTR funding.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.